Lucid Diagnostics EPS LUCD

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Lucid Diagnostics' earnings per share was −$0.90 over the twelve months to Sep 30, 2025.

In its latest quarter, Q3 FY25, it was −$0.10.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q3 FY25	Sep 30, 2025	−$0.10	n/a	−$0.90
Q2 FY25	Jun 30, 2025	−$0.08	n/a	−$1.05
Q1 FY25	Mar 31, 2025	−$0.52	n/a	−$1.20
Q4 FY24	Dec 31, 2024	−$0.20	n/a	−$1.08
Q3 FY24	Sep 30, 2024	−$0.25	n/a	−$1.14
Q2 FY24	Jun 30, 2024	−$0.23	n/a	−$1.23
Q1 FY24	Mar 31, 2024	−$0.40	n/a	−$1.27
Q4 FY23	Dec 31, 2023	−$0.26	n/a	−$1.27
Q3 FY23	Sep 30, 2023	−$0.34	n/a	−$1.41
Q2 FY23	Jun 30, 2023	−$0.27	n/a	−$1.46
Q1 FY23	Mar 31, 2023	−$0.40	n/a	−$1.60
Q4 FY22	Dec 31, 2022	−$0.40	n/a	n/a

Companies in Medical - Instruments & Supplies nearest Lucid Diagnostics' size, closest first, today.

Company	EPS, 12 months	Growth
LUCDLucid Diagnostics	n/m
KEQUKewaunee Scientific	$2.76	−33% a year
APTAlpha Pro Tech	$0.41	+24% a year
NEPHNephros	$0.16	+33% a year
PDEXPro DEX	$4.11	+52% a year
UTMDUtah Medical Products	$3.28	−12% a year
INFUInfuSystem	$0.41	+78% a year
EMBCEmbecta	$1.47	+3% a year
TCMDTactile Systems Technology	$1.08	+74% a year
MDXGMimedx	$0.04	−81% a year
MOVMovado	$1.80	+137% a year
Peer median	$1.27

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.